{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:19:11Z","timestamp":1764263951031,"version":"3.46.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["152534"],"award-info":[{"award-number":["152534"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejphar.2014.06.036","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T05:36:29Z","timestamp":1403847389000},"page":"512-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacological evidence that 5-HT1A\/1B\/1D, \u03b12-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats"],"prefix":"10.1016","volume":"740","author":[{"given":"Ma. Trinidad","family":"Villamil-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Alc\u00e1ntara-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika J.","family":"Guti\u00e9rrez-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.06.036_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1254\/jphs.13104FP","article-title":"Pharmacological evidence that dopamine inhibits the cardioaccelerator sympathetic outflow via D2-like receptors in pithed rats","volume":"123","author":"Alc\u00e1ntara-V\u00e1zquez","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.06.036_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00179325","article-title":"Alpha-1 and Alpha-2 adrenoceptor agonists induce vasoconstriction of the normotensive rat caudal artery in vitro by stimulation of a heterogeneous population of alpha-1 adrenoceptors","volume":"338","author":"Atkinson","year":"1988","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0306-3623(88)90051-1","article-title":"Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat","volume":"19","author":"Badia","year":"1988","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib4","first-page":"793","article-title":"Biochemical pharmacology of pirenzepine. Similarities with tricyclic antidepressants in antimuscarinic effects only","volume":"36","author":"Bechtel","year":"1986","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejphar.2014.06.036_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(98)00698-0","article-title":"Pharmacological characterisation of a cloned dog 5-HT1B receptor cell line","volume":"360","author":"Beer","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/pr.54.1.43","article-title":"Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors","volume":"54","author":"Boehm","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2014.06.036_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00210-008-0339-y","article-title":"Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats","volume":"379","author":"Cobos-Puc","year":"2009","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2014.06.036_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav. Brain Res."},{"issue":"Suppl.","key":"10.1016\/j.ejphar.2014.06.036_bib10","article-title":"Segmental stimulation of spinal autonomic outflows in the pithed cat and rat","volume":"211","author":"Gillespie","year":"1970","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00210-007-0221-3","article-title":"Pharmacological properties of a wide array of ergolines at functional \u03b11-adrenoceptor subtypes","volume":"376","author":"G\u00f6rnemann","year":"2008","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoceptors: an update","volume":"53","author":"Guimar\u00e3es","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2014.06.036_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.1998.tb10194.x","article-title":"Impact of the human genome project on the principles for classification and nomenclature of 5-HT receptors","volume":"861","author":"Hoyer","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2014.06.036_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1476-5381.1987.tb11338.x","article-title":"Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion","volume":"92","author":"Ireland","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(97)00631-X","article-title":"Ligand efficacy and potency at recombinant \u03b12 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding","volume":"55","author":"Jasper","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(24)37012-0","article-title":"The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299","volume":"283","author":"Johansson","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.06.036_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1476-5381.1995.tb16651.x","article-title":"Evidence that 5-HT1D receptors mediate inhibition of sympathetic ganglionic transmission in anaesthetized cats","volume":"116","author":"Jones","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000139450","article-title":"Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine2A receptors in the isolated rat aorta","volume":"53","author":"Kalkman","year":"1996","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2014.06.036_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1152\/jappl.1964.19.2.360","article-title":"Ventilation standards for small mammals","volume":"19","author":"Kleinman","year":"1964","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib20","series-title":"The Pharmacological Basis of Migraine Therapy","first-page":"255","article-title":"in vitro binding profile of drugs used in migraine","author":"Leysen","year":"1984"},{"key":"10.1016\/j.ejphar.2014.06.036_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1742-7843.2011.00762.x","article-title":"The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D2-like type","volume":"109","author":"Manrique-Maldonado","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00542142","article-title":"Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man","volume":"26","author":"Maurer","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2014.06.036_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autneu.2008.07.007","article-title":"Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats","volume":"143","author":"Monroy-Ordo\u00f1ez","year":"2008","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.ejphar.2014.06.036_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(97)00131-3","article-title":"The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons","volume":"325","author":"Mos","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF00541928","article-title":"Pharmacological actions of the main metabolites of dihydroergotamine","volume":"26","author":"M\u00fcller-Schweinitzer","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00005344-198706000-00008","article-title":"Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs","volume":"9","author":"M\u00fcller-Schweinitzer","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","article-title":"Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study","volume":"355","author":"Newman-Tancredi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1527-3458.1996.tb00309.x","article-title":"Pharmacological properties of a putative 5-HT1B\/D receptor antagonist GR127935","volume":"2","author":"Pauwels","year":"1996","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2014.06.036_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(96)00011-8","article-title":"Selective antagonism of human 5-HT1D and 5-HT1B receptor-mediated responses in stably transfected C6-glial cells by ketanserin and GR 127,935","volume":"300","author":"Pauwels","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/PL00005056","article-title":"SB-216641 and BRL-15572\u2014compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors","volume":"356","author":"Price","year":"1997","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00210-013-0841-8","article-title":"Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats","volume":"386","author":"Ruiz-Salinas","year":"2013","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.06.036_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3181\/00379727-64-15828","article-title":"A pithed rat preparation suitable for assaying pressor substances","volume":"64","author":"Shipley","year":"1947","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2014.06.036_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1526-4610.2003.03034.x","article-title":"Ergotamine and dihydroergotamine: history, pharmacology, and efficacy","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.ejphar.2014.06.036_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0166-4328(96)00089-7","article-title":"GR127935: a potent and selective 5-HT1D receptor antagonist","volume":"73","author":"Skingle","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.06.036_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BFb0027645","article-title":"Presynaptic alpha-autoreceptors","volume":"107","author":"Starke","year":"1987","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"year":"1980","series-title":"Principles and Procedures of Statistics: A Biomedical Approach","author":"Steel","key":"10.1016\/j.ejphar.2014.06.036_bib38"},{"key":"10.1016\/j.ejphar.2014.06.036_bib39","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0022-3565(24)35030-X","article-title":"Effect of several 5-hydroxytryptamine1A receptor ligands on the micturition reflex in rats: comparison with WAY 100635","volume":"290","author":"Testa","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2014.06.036_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2014.06.036_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00210-003-0829-x","article-title":"All three \u03b12-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons","volume":"368","author":"Trendelenburg","year":"2003","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00210-004-0947-0","article-title":"5-HT1B receptors, \u03b12A\/2C- and, to a lesser extent, \u03b11-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs","volume":"370","author":"Valdivia","year":"2004","journal-title":"Naunyn-Schmiedeberg\u05f3s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0026-895X(25)08940-0","article-title":"Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype","volume":"42","author":"Veldman","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib44","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bjp.0701907","article-title":"The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes","volume":"124","author":"Villal\u00f3n","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2013.05.011","article-title":"Pharmacological identification of \u03b11- and \u03b12-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats","volume":"715","author":"Villamil-Hern\u00e1ndez","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.06.036_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2013.08.025","article-title":"The \u03b12-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with \u03b12A, \u03b12B and \u03b12C subtypes","volume":"718","author":"Villamil-Hern\u00e1ndez","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914004877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914004877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:15:10Z","timestamp":1764263710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914004877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":46,"alternative-id":["S0014299914004877"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.06.036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evidence that 5-HT1A\/1B\/1D, \u03b12-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}